AI-generated summary
The authors report a randomized clinical trial of 106 adults with non-specific chronic low back pain comparing 650 nm invasive laser acupuncture with sham treatment over four weeks. They report that the treatment group was more likely to achieve at least a 30% pain reduction at the 3-day post-treatment endpoint, with an odds ratio of 4.69. The abstract describes the study as conducted in two Korean hospitals.
- Participants
- 106
- Who or what was studied
- Adults with non-specific chronic low back pain treated at two hospitals in Korea
- Wavelengths
- 650 nm
- Limits stated in the abstract
- The abstract does not describe blinding or long-term follow-up, and the evidence is from a single trial conducted in two Korean hospitals.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
The study aims to determine whether 650 nm invasive laser acupuncture (ILA) is safe and effective for pain relief in patients with non-specific chronic low back pain (NSCLBP).
Methods
This randomized clinical trial was conducted in two hospitals in Korea. Individuals with NSCLBP were randomized into two groups: an ILA group and a control group, in a ratio of 1:1. One hundred six participants with NSCLBP were equally assigned to the 650 nm ILA group and the control group. The 650 nm ILA group underwent 650 nm ILA for 10 min, and the control group received sham ILA for 10 min per visit, twice a week for 4 weeks, bilaterally at the GB30, BL23, BL24, and BL25 acupuncture points. All participants were trained on exercise and self-management. The primary outcome was the responder rate at the 3-day post-treatment endpoint, defined as the proportion of patients with more than a 30% reduction in NSCLBP.
Results
At the 3-day post-treatment endpoint, participants in the treatment group were approximately 36% more likely to respond to the treatment than those in the control group (odds ratio 4.69; 95% confidence interval, 2.04, 10.79; p < 0.001), indicating a statistically significant difference in responder rates between the two groups.
Conclusion
Our study provides clinical evidence for the safety and efficacy of 650 nm ILA in managing of NSCLBP. This is the first study to use ILA, which differs from previously used conventional laser acupuncture. SYSTEMATIC REVIEW
Registration
https://cris.nih.go.kr/cris/search/detailSearch.do?search_lang=E&focus=reset_12&search_page=M&pageSize=10&page=undefined&seq=21591&status=5&seq_group=21591, identifier registration KCT0007167.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Control group, Confidence interval, Systematic review, Primary outcome, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.